BioLineRX stem cell leukaemia drug meets goals in early trial – Reuters
Channel News Asia |
BioLineRX stem cell leukaemia drug meets goals in early trial
Reuters Current stem cell treatments require four or five days of injections of material from a donor to get into the bloodstream, but BioLineRX said its treatment, currently called BL-8040, needed just one. "The results support BL-8040 as a one-day, single … BioLineRx Reports Successful Top-Line Safety and Efficacy Results for Novel … Leukemia Drug Shows Promise in Early Trial |
